Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmati Aim Vct Regulatory News (AMAT)

  • There is currently no data for AMAT

Issue of Equity

25 Aug 2021 09:53

RNS Number : 7480J
Amati AIM VCT PLC
25 August 2021
 

Amati AIM VCT plc

25 August 2021

 

Amati AIM VCT plc (the "Company")

Legal Entity Identifier: 213800HAEDBBK9RWCD25

Issue of Equity

The Board of Amati AIM VCT plc (the "Company") is pleased to announce that on 23 August 2021 it allotted 4,158,772 new Ordinary Shares of 5p each in the capital of the Company ("Ordinary Shares") pursuant to the Offer for Subscription launched on 30 July 2021 (the "Offer"). In accordance with the terms and conditions of the Offer, the price at which 4,142,726 new Ordinary Shares were allotted, which was calculated by reference to the net asset value of an Ordinary Share on 19 August 2021, was 219.67p per Ordinary Share (net asset value divided by 0.99 to allow for issue costs of 1.0%) and the price at which 16,046 new Ordinary Shares were allotted, which was calculated by reference to the net asset value of an Ordinary Share on 5 August 2021, was 218.10p per Ordinary Share (net asset value divided by 0.99 to allow for issue costs of 1.0%)

As announced on 4 August 2021, the Offer is fully subscribed and currently closed for new applications unless and until the Board decides to utilise the over-allotment facility, in which case a further announcement will be made.

Applications have been made for the new Ordinary Shares to be admitted to the Official List of the FCA (with a Premium Listing) and to the London Stock Exchange for admission to trading on the main market for listed securities. It is expected that admission will occur and dealing will commence in the new Ordinary Shares on or around 31 August 2021.

As a result of the issue, the total number of Ordinary Shares in issue will be 137,072,218 and the total number of voting rights in the Company will be 137,072,218. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Disclosure Guidance and Transparency Rules.

For further information, please contact the investor line at Amati Global Investors on 0131 503 9115 or by email at info@amatiglobal.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEDKPBPFBKKDFB
Date   Source Headline
6th Dec 20245:00 pmRNSNet Asset Value(s)
3rd Dec 20244:40 pmRNSTransaction in Own Shares
3rd Dec 202410:05 amRNSNet Asset Value(s)
2nd Dec 202411:20 amRNSTotal Voting Rights
2nd Dec 20247:00 amRNSConclusion of Strategic Review & Change of Manager
25th Nov 202410:58 amRNSNet Asset Value(s)
18th Nov 202412:07 pmRNSTransaction in Own Shares
15th Nov 20244:14 pmRNSNet Asset Value(s)
8th Nov 20244:12 pmRNSNet Asset Value(s)
1st Nov 20244:28 pmRNSNet Asset Value(s)
1st Nov 20243:15 pmRNSTotal Voting Rights
30th Oct 20243:34 pmRNSTransaction in Own Shares
29th Oct 20241:26 pmRNSTransaction in Own Shares
28th Oct 20249:36 amRNSNet Asset Value(s)
22nd Oct 20242:05 pmRNSTransaction in Own Shares
21st Oct 20249:50 amRNSNet Asset Value(s)
14th Oct 20243:33 pmRNSTransaction in Own Shares
11th Oct 20244:40 pmRNSNet Asset Value(s)
8th Oct 20244:22 pmRNSTransaction in Own Shares
7th Oct 20241:16 pmRNSNet Asset Value(s)
2nd Oct 202410:36 amRNSNet Asset Value(s)
1st Oct 202410:00 amRNSTotal Voting Rights
27th Sep 20247:00 amRNSHalf-year Report
25th Sep 20243:12 pmRNSTransaction in Own Shares
23rd Sep 202410:28 amRNSNet Asset Value(s)
19th Sep 20249:12 amRNSDividend Declaration
13th Sep 20245:12 pmRNSNet Asset Value(s)
11th Sep 202411:05 amRNSTransaction in Own Shares
6th Sep 20244:57 pmRNSNet Asset Value(s)
4th Sep 20244:35 pmRNSTransaction in Own Shares
3rd Sep 20242:55 pmRNSNet Asset Value(s)
3rd Sep 20247:00 amRNSUpdate on Strategic Review
2nd Sep 202411:13 amRNSCompliance with Market Abuse Regulation
2nd Sep 202411:01 amRNSTotal Voting Rights
23rd Aug 20245:42 pmRNSNet Asset Value(s)
16th Aug 20244:39 pmRNSNet Asset Value(s)
12th Aug 20244:50 pmRNSTransaction in Own Shares
9th Aug 20245:18 pmRNSNet Asset Value(s)
5th Aug 20241:40 pmRNSTransaction in Own Shares
2nd Aug 202410:05 amRNSNet Asset Value(s)
1st Aug 20244:37 pmRNSTransaction in Own Shares
1st Aug 202411:40 amRNSTotal Voting Rights
26th Jul 20243:40 pmRNSNet Asset Value(s)
24th Jul 20242:31 pmRNSTransaction in Own Shares
23rd Jul 20242:45 pmRNSTransaction in Own Shares
22nd Jul 202410:31 amRNSNet Asset Value(s)
15th Jul 20245:16 pmRNSNet Asset Value(s)
8th Jul 202410:40 amRNSNet Asset Value(s)
2nd Jul 202412:02 pmRNSNet Asset Value(s)
1st Jul 20243:50 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.